Matching articles for "ulipristal acetate"
Choice of Contraceptives
The Medical Letter on Drugs and Therapeutics • May 15, 2023; (Issue 1676)
Intrauterine devices (IUDs) and the etonogestrel
implant are the most effective reversible contraceptive
methods available. Hormonal oral contraceptives,
patches, rings, and injectables are also effective...
Intrauterine devices (IUDs) and the etonogestrel
implant are the most effective reversible contraceptive
methods available. Hormonal oral contraceptives,
patches, rings, and injectables are also effective in
preventing pregnancy. When used alone, barrier and
behavioral methods generally have higher failure
rates than other methods (see Table 1). Selection of
a contraceptive method is usually based on patient-specific factors and personal preference
Choice of Contraceptives
The Medical Letter on Drugs and Therapeutics • October 8, 2018; (Issue 1557)
Intrauterine devices (IUDs) and the etonogestrel
implant are the most effective reversible contraceptive
methods available. Hormonal oral contraceptives,
patches, rings, and injectables are also highly...
Intrauterine devices (IUDs) and the etonogestrel
implant are the most effective reversible contraceptive
methods available. Hormonal oral contraceptives,
patches, rings, and injectables are also highly effective
in preventing pregnancy. When used alone, barrier and
fertility-based methods generally have higher failure
rates than other methods.
Choice of Contraceptives
The Medical Letter on Drugs and Therapeutics • September 14, 2015; (Issue 1477)
Implants, intrauterine devices (IUDs), and sterilization
are the most effective contraceptive methods available.
Pills, patches, rings, and injectables, when used
correctly, are also highly effective in...
Implants, intrauterine devices (IUDs), and sterilization
are the most effective contraceptive methods available.
Pills, patches, rings, and injectables, when used
correctly, are also highly effective in preventing pregnancy.
Barrier and fertility-based methods have the
highest rates of failure.
In Brief: Plan B One-Step OTC
The Medical Letter on Drugs and Therapeutics • June 24, 2013; (Issue 1419)
The progestin levonorgestrel is available over the counter for emergency contraception as two 0.75-mg tablets taken 12 hours apart (generic formulations of Plan B) and as a single 1.5-mg tablet taken once (Plan...
The progestin levonorgestrel is available over the counter for emergency contraception as two 0.75-mg tablets taken 12 hours apart (generic formulations of Plan B) and as a single 1.5-mg tablet taken once (Plan B One-Step, and generics). A third emergency contraceptive, ulipristal (Ella – Watson), is available with a prescription.1 It appears that, pursuant to a court order, Plan B One-Step (but not the generic products), which was previously available over the counter from a pharmacist only for women 17 years and older, will now be available directly from pharmacy shelves with no age restrictions.
EMERGENCY CONTRACEPTION — Currently used hormonal methods of emergency contraception, which apparently mainly prevent or delay ovulation, can prevent 50-80% of pregnancies.2 They should be started as soon as possible within 72 hours after unprotected intercourse. One study found that taking levonorgestrel as late as 120 hours after unprotected intercourse could still be effective.3
Many oral contraceptives can be used in doses suitable for emergency contraception. All are recommended for use in 2 doses 12 hours apart, but given the effectiveness of a single dose of levonorgestrel 1.5 mg in Plan B One-Step, taking the tablets all at once might be an option. Patients who vomit within 1 hour of administration can repeat the dose. A copper IUD inserted within 5 days after intercourse can also provide emergency contraception.
ADVERSE EFFECTS — Nausea and vomiting occur less frequently with levonorgestrel alone than with estrogen-progestin combinations. Headache, abdominal pain and breast tenderness have been reported with either progestin-only or combination oral contraceptives. No fetal malformations caused by unsuccessful use of hormones for emergency contraception have been reported.
1. Ella: a new emergency contraceptive. Med Lett Drugs Ther 2011; 53:3.
2. DT Baird. Emergency contraception: how does it work? Reprod Biomed Online 2009; 18 suppl 1:32.
3. H von Hertzen et al. Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicentre randomised trial. Lancet 2002; 360:1803.
Download complete U.S. English article
EMERGENCY CONTRACEPTION — Currently used hormonal methods of emergency contraception, which apparently mainly prevent or delay ovulation, can prevent 50-80% of pregnancies.2 They should be started as soon as possible within 72 hours after unprotected intercourse. One study found that taking levonorgestrel as late as 120 hours after unprotected intercourse could still be effective.3
Many oral contraceptives can be used in doses suitable for emergency contraception. All are recommended for use in 2 doses 12 hours apart, but given the effectiveness of a single dose of levonorgestrel 1.5 mg in Plan B One-Step, taking the tablets all at once might be an option. Patients who vomit within 1 hour of administration can repeat the dose. A copper IUD inserted within 5 days after intercourse can also provide emergency contraception.
ADVERSE EFFECTS — Nausea and vomiting occur less frequently with levonorgestrel alone than with estrogen-progestin combinations. Headache, abdominal pain and breast tenderness have been reported with either progestin-only or combination oral contraceptives. No fetal malformations caused by unsuccessful use of hormones for emergency contraception have been reported.
1. Ella: a new emergency contraceptive. Med Lett Drugs Ther 2011; 53:3.
2. DT Baird. Emergency contraception: how does it work? Reprod Biomed Online 2009; 18 suppl 1:32.
3. H von Hertzen et al. Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicentre randomised trial. Lancet 2002; 360:1803.
Download complete U.S. English article
Ella: A New Emergency Contraceptive
The Medical Letter on Drugs and Therapeutics • January 10, 2011; (Issue 1355)
The FDA has approved the use of ulipristal acetate
(ella – Watson) as an emergency contraceptive that
can be taken up to 5 days after unprotected intercourse.
It is available only by...
The FDA has approved the use of ulipristal acetate
(ella – Watson) as an emergency contraceptive that
can be taken up to 5 days after unprotected intercourse.
It is available only by prescription.
Choice of Contraceptives
The Medical Letter on Drugs and Therapeutics • December 1, 2010; (Issue 100)
The choice of which contraceptive to use may vary from one stage of reproductive life to another. Intrauterine devices (IUDs), progestin implants and sterilization are the most effective contraceptive methods...
The choice of which contraceptive to use may vary from one stage of reproductive life to another. Intrauterine devices (IUDs), progestin implants and sterilization are the most effective contraceptive methods available to women. Hormonal contraceptives, when used correctly, are also highly effective in preventing pregnancy. Barrier and fertility-based methods
have the highest rate of failure.